The costs of adverse drug events in community hospitals

Joint Commission Journal on Quality and Patient Safety

Volumn 38, Issue 3, 2012, Pages 120-126

  Hug, Balthasar L ^a   Keohane, Carol ^b   Seger, Diane L ^c   Yoon, Catherine ^b   Bates, David W ^b,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c PARTNERS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMMUNITY HOSPITAL; DRUG TOXICITY; ECONOMICS; FEMALE; HEALTH INSURANCE; HOSPITAL BED CAPACITY; HOSPITAL CHARGE; HOSPITAL COST; HUMAN; LENGTH OF STAY; MALE; MEDICATION ERROR; MIDDLE AGED; MULTICENTER STUDY; RACE; RETROSPECTIVE STUDY; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; DRUG TOXICITY; FEMALE; HOSPITAL BED CAPACITY, 100 TO 299; HOSPITAL CHARGES; HOSPITAL COSTS; HOSPITALS, COMMUNITY; HUMANS; INSURANCE, HEALTH; LENGTH OF STAY; MALE; MEDICATION ERRORS; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84857263446     PISSN: 15537250     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1553-7250(12)38016-1     Document Type: Article

References (17)

1. Leape LL, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991 Feb 7;324(6):377-384.
2. Bates DW, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995 Jul 5;274(1):29-34.
3. Kohn LT, Corrigan JM, Donaldson MS. To Err Is human: Building a Safer Health Care System. Washington DC: National Academy Press, 2000.
4. Classen DC, et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA.1997 Jan 22-29;277(4): 301-306. (Pubitemid 27045010)
5. Bates DW, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997 Jan 22-29;277(4): 307-311. (Pubitemid 27045011)
6. Piontek F, et al. Effects of an adverse-drug-event alert system on cost and quality outcomes in community hospitals. Am J Health Syst Pharm. 2010 Apr 15;67(8):613-620.
7. Centers for Medicare & Medicaid Services. Hospital-Acquired Conditions (Present on Admission Indicator). (Updated Sep 29, 2011.) Accessed Jan 19, 2012. https://www.cms.gov/hospitalacqcond/.
8. Fisher ES, Shortell SM. Accountable care organizations: Accountable for what, to whom, and how. JAMA. 2010 Oct 20;304(15):1715-1716.
9. Bates DW, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998 Oct 21;280(15):1311-1316. (Pubitemid 28473716)
10. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: A systematic review. Arch Intern Med. 2003 Jun 23;163(12):1409-1416. (Pubitemid 36758913)
11. Massachusetts Technology Collaborative: About the CPOE Initiative. Feb 2008. Accessed Jan 19, 2012. http://www.masstech.org/ehealth/cpoe.html.
12. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: A practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12(3):194-200. (Pubitemid 36723946)
13. Institute for Healthcare Improvement. IHI Global Trigger Tool for Measuring Adverse Events. Accessed Jan 23, 2012. http://www.ihi.org/knowledge/ Pages/Tools/IHIGlobalTriggerToolforMeasuringAEs.aspx.
14. Hug BL, et al. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int. 2009;76(11):1192-1198.
15. Hug BL, et al. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention. J Gen Intern Med. 2009;25(1):31-38.
16. Bates DW, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10(4):199-205.
17. Krähenbuhl-Melcher A, et al. Drug-related problems in hospitals: A review of the recent literature. Drug Saf. 2007;30(5):379-407. (Pubitemid 46740336)